Lacticaseibacillus rhamnosus Reduces the Pathogenicity of Escherichia coli in Chickens

Lacticaseibacillus rhamnosus is a recognized probiotic that is widely used in scientific research and clinical applications. This study found that the Lacticaseibacillus rhamnosus GG (LGG) strain can reduce the adhesion of Escherichia coli (E. coli) to primary chicken intestinal epithelial cells by...

Full description

Bibliographic Details
Main Authors: Mengjiao Guo, Congyue Zhang, Chengcheng Zhang, Xiaorong Zhang, Yantao Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2021.664604/full
id doaj-421c9142eb8f44f5bf859c2e41d44f7f
record_format Article
spelling doaj-421c9142eb8f44f5bf859c2e41d44f7f2021-06-01T04:20:44ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2021-06-011210.3389/fmicb.2021.664604664604Lacticaseibacillus rhamnosus Reduces the Pathogenicity of Escherichia coli in ChickensMengjiao Guo0Congyue Zhang1Chengcheng Zhang2Xiaorong Zhang3Yantao Wu4Yantao Wu5Jiangsu Co-Innovation Center for Prevention of Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou University, Yangzhou, ChinaJiangsu Co-Innovation Center for Prevention of Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou University, Yangzhou, ChinaJiangsu Co-Innovation Center for Prevention of Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou University, Yangzhou, ChinaJiangsu Co-Innovation Center for Prevention of Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou University, Yangzhou, ChinaJiangsu Co-Innovation Center for Prevention of Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou University, Yangzhou, ChinaJoint International Research Laboratory of Agriculture and Agri-Product Safety, Yangzhou University (JIRLAAPS), Yangzhou, ChinaLacticaseibacillus rhamnosus is a recognized probiotic that is widely used in scientific research and clinical applications. This study found that the Lacticaseibacillus rhamnosus GG (LGG) strain can reduce the adhesion of Escherichia coli (E. coli) to primary chicken intestinal epithelial cells by 75.7% and inhibit 41.7% of the E. coli that adhere to intestinal epithelial cells. Additionally, LGG showed strong inhibitory ability on the growth of E. coli, Staphylococcus aureus, Salmonella Paratyphi B, and Salmonella Enteritidis in vitro. Furthermore, the influence of LGG on the growth performance, intestinal flora, immunity, and disease resistance of chickens was explored. Chickens fed with LGG exhibited increased average daily weight gain and concentrations of sIgA, IgG, and IgM than did controls. After 21 days of feeding, a diet with LGG increased the diversity of intestinal microbiota and maintained intestinal health. Moreover, LGG promoted immunologic barriers by upregulating cytokines and chemokines via the Toll-like receptor. The major pro-inflammatory factors, including Myd88, NF-κB, Il6, and Il8, were upregulated compared to controls. After being challenged with E. coli, the survival rate of chickens fed with LGG was significantly higher than those in the control group, and decreased numbers of E. coli were detected in the heart and lungs of the LGG group. In summary, oral administration of LGG to chickens could improve growth performance, maintain intestinal homeostasis, and enhance innate immune response and disease resistance.https://www.frontiersin.org/articles/10.3389/fmicb.2021.664604/fulladhesionintestinal microbiotainnate immune responsedisease resistanceLacticaseibacillus rhamnosus
collection DOAJ
language English
format Article
sources DOAJ
author Mengjiao Guo
Congyue Zhang
Chengcheng Zhang
Xiaorong Zhang
Yantao Wu
Yantao Wu
spellingShingle Mengjiao Guo
Congyue Zhang
Chengcheng Zhang
Xiaorong Zhang
Yantao Wu
Yantao Wu
Lacticaseibacillus rhamnosus Reduces the Pathogenicity of Escherichia coli in Chickens
Frontiers in Microbiology
adhesion
intestinal microbiota
innate immune response
disease resistance
Lacticaseibacillus rhamnosus
author_facet Mengjiao Guo
Congyue Zhang
Chengcheng Zhang
Xiaorong Zhang
Yantao Wu
Yantao Wu
author_sort Mengjiao Guo
title Lacticaseibacillus rhamnosus Reduces the Pathogenicity of Escherichia coli in Chickens
title_short Lacticaseibacillus rhamnosus Reduces the Pathogenicity of Escherichia coli in Chickens
title_full Lacticaseibacillus rhamnosus Reduces the Pathogenicity of Escherichia coli in Chickens
title_fullStr Lacticaseibacillus rhamnosus Reduces the Pathogenicity of Escherichia coli in Chickens
title_full_unstemmed Lacticaseibacillus rhamnosus Reduces the Pathogenicity of Escherichia coli in Chickens
title_sort lacticaseibacillus rhamnosus reduces the pathogenicity of escherichia coli in chickens
publisher Frontiers Media S.A.
series Frontiers in Microbiology
issn 1664-302X
publishDate 2021-06-01
description Lacticaseibacillus rhamnosus is a recognized probiotic that is widely used in scientific research and clinical applications. This study found that the Lacticaseibacillus rhamnosus GG (LGG) strain can reduce the adhesion of Escherichia coli (E. coli) to primary chicken intestinal epithelial cells by 75.7% and inhibit 41.7% of the E. coli that adhere to intestinal epithelial cells. Additionally, LGG showed strong inhibitory ability on the growth of E. coli, Staphylococcus aureus, Salmonella Paratyphi B, and Salmonella Enteritidis in vitro. Furthermore, the influence of LGG on the growth performance, intestinal flora, immunity, and disease resistance of chickens was explored. Chickens fed with LGG exhibited increased average daily weight gain and concentrations of sIgA, IgG, and IgM than did controls. After 21 days of feeding, a diet with LGG increased the diversity of intestinal microbiota and maintained intestinal health. Moreover, LGG promoted immunologic barriers by upregulating cytokines and chemokines via the Toll-like receptor. The major pro-inflammatory factors, including Myd88, NF-κB, Il6, and Il8, were upregulated compared to controls. After being challenged with E. coli, the survival rate of chickens fed with LGG was significantly higher than those in the control group, and decreased numbers of E. coli were detected in the heart and lungs of the LGG group. In summary, oral administration of LGG to chickens could improve growth performance, maintain intestinal homeostasis, and enhance innate immune response and disease resistance.
topic adhesion
intestinal microbiota
innate immune response
disease resistance
Lacticaseibacillus rhamnosus
url https://www.frontiersin.org/articles/10.3389/fmicb.2021.664604/full
work_keys_str_mv AT mengjiaoguo lacticaseibacillusrhamnosusreducesthepathogenicityofescherichiacoliinchickens
AT congyuezhang lacticaseibacillusrhamnosusreducesthepathogenicityofescherichiacoliinchickens
AT chengchengzhang lacticaseibacillusrhamnosusreducesthepathogenicityofescherichiacoliinchickens
AT xiaorongzhang lacticaseibacillusrhamnosusreducesthepathogenicityofescherichiacoliinchickens
AT yantaowu lacticaseibacillusrhamnosusreducesthepathogenicityofescherichiacoliinchickens
AT yantaowu lacticaseibacillusrhamnosusreducesthepathogenicityofescherichiacoliinchickens
_version_ 1721411231246450688